Bill > S1036

This bill establishes a moratorium on the administration of human gene therapy products for infectious disease treatments, named the "Doug Cameron Act" after an Idaho rancher who reportedly suffered severe injuries from a genetic immunization. The legislation defines "human gene therapy products" broadly to include nucleic acids, genetically modified microorganisms, genome editing tools, and genetically modified human cells, and prohibits their use for infectious disease treatments through July 1, 2035. The bill specifically exempts gene therapy products used for cancer or genetic disorder treatments. The legislative intent section emphasizes protecting Idaho residents from potential adverse effects of experimental gene therapies and calls for increased caution, transparency, and oversight in deploying such treatments. The law will take effect immediately on July 1, 2025, and requires legislative review of safety data during the moratorium period. By establishing this temporary ban, the bill aims to prevent potential harm from what legislators perceive as experimental and potentially risky medical interventions while allowing time for further scientific evaluation and safety assessment.

Health and Social Services, Justice

Health and Welfare Committee (Senate)

https://legislature.idaho.gov/sessioninfo/2025/legislation/S1036/